Unsupervised Disentanglement of Brain Heterogeneity for Identifying Subtypes of Alzheimer's Disease

Insights

This study introduces 3D-DisAD, a deep learning tool that identifies Alzheimer's disease (AD) subtypes by isolating AD-specific brain changes. This approach enables more precise patient stratification and personalized treatments for Alzheimer's disease.

Area of Science:

  • Neuroimaging
  • Artificial Intelligence
  • Neurology

Background:

  • Neuroanatomical heterogeneity in Alzheimer's disease (AD) complicates precise diagnosis and treatment.
  • Existing MRI-based classifications are often confounded by non-AD factors, limiting clinical interpretability.

Purpose of the Study:

  • To develop an unsupervised deep learning framework (3D-DisAD) to disentangle AD-specific neuroanatomical variations from unrelated influences.
  • To cluster patients into subtypes with homogeneous brain phenotypes for improved patient stratification.

Main Methods:

  • The 3D-DisAD framework utilizes a Contrastive Disentanglement Network to separate AD-specific variations from shared variations between AD patients and healthy controls.
  • A Transformation Generation Network refines disease-specific variations using diffusion-based generative modeling to create pathology-consistent anatomies.

Main Results:

  • 3D-DisAD demonstrated strong correlations between disentangled AD-specific variations and clinical/biological profiles across four public datasets.
  • Four distinct AD subtypes were identified, showing significant differences in biomarkers, cognitive trajectories, and genetic signatures.
  • Distinct longitudinal progression patterns were uncovered, suggesting potential windows for early intervention.

Conclusions:

  • 3D-DisAD effectively disentangles AD-specific neuroanatomical variations, enabling more precise patient stratification.
  • The identified subtypes offer insights into distinct disease progression pathways, facilitating personalized treatment strategies, especially in early-stage AD.